China Pharma MCP server

@pipeworx/china-pharma

Biotech and pharmaceutical licensing deals and drug approvals involving China, read out of SEC 8-K and HKEX disclosure announcements. Keyless.

Part of Pipeworx — an MCP gateway connecting AI agents to 1576+ live data sources.

Tools

out-licensed an asset to a Western partner, or a Western company licensed rights into Greater China. Returns both companies, the territory clause, upfront and milestone amounts, royalty language, and the filing it was announced in.

• chinalicensingdeals(query?, since?, until?, limit?) — deals where a Chinese company

import rules, clinical-trial guideline updates. Sections: news, drugs, devices, cosmetics. NOT the approvals register — see below.

• nmpa_updates(section?, limit?) — official NMPA announcements in English: policy, guidance,

conditionally approved, or given an expanded indication by NMPA, read out of HKEX (Hong Kong Exchange) disclosure filings. Returns the filing headline, company, approval date, a best-effort category, and the filing PDF.

• nmpadrugapprovals(month? | since?/until?, query?, limit?) — specific drugs approved,

nmpadrugapprovals, or by drug/company name search.

• nmpadrugapproval(id? | name?) — one approval record by the id from

from the CSRC, China's securities regulator, newest first from csrc.gov.cn's own JSON feed. Each row carries the decision number, publication date, the first named party, a memo excerpt with the remaining parties, and the link to the full decision. Securities enforcement — disclosure fraud, insider trading, audit failures — not drug regulation.

• csrc_penalties(since?, page?, limit?) — administrative penalty decisions (行政处罚决定书)

What nmpa_updates is not, and where the approvals actually come from

nmpaupdates is not** the drug-approval register, and neither — contrary to what it looks like on a first read — is english.nmpa.gov.cn/drugs.html. Probing it live (2026-09-07) rather than trusting the page name: every section (drugs, news, policies, regulatoryinformation) is a paginated feed of administrative-policy notices ("Announcement on Strengthening Supervision of Contract Manufacturing", "Policy Interpretation of..."), the newest item under drugs is dated 2026-04-14 — five months stale against a September run — and not one entry across any section names a specific drug as approved. The Chinese-language NMPA site (all paths, not just /datasearch/, confirmed domain-wide this run) and CDE both still answer HTTP 412/202 with a 瑞数/Riverdata JS-obfuscation challenge to a plain non-Cloudflare client — the 2026-08-11 finding holds. Reading either needs a headless browser, which a stateless pack cannot be.

What actually carries approval events, keyless and current: any HKEX-listed Chinese biotech is required to disclose an NMPA approval as a same-day regulatory filing, and HKEXnews' public title-search JSON endpoint (titleSearchServlet.do) serves those without a key — the same trick chinalicensingdeals already uses one exchange over (SEC 8-Ks instead of HKEX filings): the curated register isn't public, but the disclosure layer is. nmpadrugapprovals and nmpadrugapproval are built on that.

Traps

Shortened. The full README is on GitHub.